Wan-Ju Lee

4PUBLICATIONS
36CO-AUTHORS
Environmental epidemiologyClinimetricsGene and molecular therapyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 02, 2025
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis.

Eric L Simpson, Jonathan I Silverberg, Vimal H Prajapati

|Aug 06, 2024
Content Validity and Psychometric Evaluation of the Crohn's Symptom Severity (CSS) Questionnaire in Patients with Moderately to Severely Active Crohn's Disease.

Edouard Louis, Wan-Ju Lee, Leighann Litcher-Kelly

|May 02, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).

Eric L Simpson, Vimal H Prajapati, Yael A Leshem

|Mar 26, 2024
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).

Jonathan I Silverberg, Melinda J Gooderham, Amy S Paller

Pageof 1

Frequent Collaborators

3 joint publications

Jonathan I Silverberg

3 joint publications

Brian M Calimlim

2 joint publications

Marjolein S de Bruin-Weller

2 joint publications

Vimal H Prajapati